IMW 2019 | Varying VRd regimens in real-world patients

Surbhi Sidana

Surbhi Sidana, MBBS Mayo Clinic, Rochester, MN, presents results on investigations into different regiments of bortezomib, lenalidomide, dexamethasone (VRd) and their efficacy and toxicity in real-world patients at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

Share this video